Pyro Pharmaceuticals Overview
- Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Pyro Pharmaceuticals General Information
Description
Provider of pharmaceutical research services. The company is engaged in the research and development of drugs and pharmaceutical products.
Contact Information
Website
www.pyropharmaceuticals.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Acquirer
Primary Office
- 315 Marna Avenue
- Long Beach, CA 90808
- United States
Pyro Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pyro Pharmaceuticals Patents
Pyro Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20030232021-A1 | Administering effective amount of a compound capable of inhibiting an enzyme that is important to energy storage or utilization in microorganism | Inactive | 12-Apr-2002 | 00000000 | 00 |
| US-6955890-B2 | Identifying a metabolic pathway in a pathogenic microorganism that is essential to the viability of the microorganism, detecting an enzyme in such pathway which is not present in the mammal, identifying the compound that inhibit the enzyme | Inactive | 14-Feb-2002 | 00000000 | 0 |
| US-20030180830-A1 | Identifying a metabolic pathway in a pathogenic microorganism that is essential to the viability of the microorganism, detecting an enzyme in such pathway which is not present in the mammal, identifying the compound that inhibit the enzyme | Active | 14-Feb-2002 | 00000000 | 0 |
| US-20040006040-A1 | Administering compound capable of inhibiting enzyme that is important in glucose metabolism, coenzyme a biosynthesis, biotin metabolism, reductive carboxylation, riboflavin biosynthesis or thiamine biosynthesis in microorganism | Inactive | 14-Feb-2002 | C12Q1/18 | 0 |
Pyro Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|